Health
A target for potential cancer drugs may, in fact, worsen disease – EurekAlert
Researchers reveal a previously unrealized complexity in cancer development, one that raises concerns and caution about targeting…
In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyrosine phosphatase 2 or more briefly, Shp2.
Shp2 is a phosphotyrosine phosphatase; its…
Continue Reading
-
General24 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News21 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
Noosa News23 hours agoMan dies in Gold Coast after rolling trailer pins him to lamp-post
-
General17 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank